CFTR c.59_60delinsAG ;(p.T20K)

Variant ID: 7-117144312-CC-AG

NM_000492.3(CFTR):c.59_60delinsAG;(p.T20K)

This variant was identified in 2 publications

View GRCh38 version.




Publications:


YAP1 mediates survival of ALK-rearranged lung cancer cells treated with alectinib via pro-apoptotic protein regulation.

Nature Communications
Tsuji, Takahiro T; Ozasa, Hiroaki H; Aoki, Wataru W; Aburaya, Shunsuke S; Yamamoto Funazo, Tomoko T; Furugaki, Koh K; Yoshimura, Yasushi Y; Yamazoe, Masatoshi M; Ajimizu, Hitomi H; Yasuda, Yuto Y; Nomizo, Takashi T; Yoshida, Hironori H; Sakamori, Yuichi Y; Wake, Hiroaki H; Ueda, Mitsuyoshi M; Kim, Young Hak YH; Hirai, Toyohiro T
Publication Date: 2020-01-03

Variant appearance in text: CFTR/MRP: T20K
PubMed Link: 31900393
Variant Present in the following documents:
  • 41467_2019_13771_MOESM5_ESM.xlsx, sheet 1
View BVdb publication page



Understanding Cell Penetration of Cyclic Peptides.

Chemical Reviews
Dougherty, Patrick G PG; Sahni, Ashweta A; Pei, Dehua D
Publication Date: 2019-09-11

Variant appearance in text: CFTR: T20K
PubMed Link: 31083977
Variant Present in the following documents:
  • Main text
View BVdb publication page